Cargando…

Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis

Insulin stimulates lipogenesis but insulin resistance is also associated with increased hepatic lipogenesis in obesity. However, the underlying mechanism remains poorly characterized. Here, we show a noncanonical insulin-Snail1 pathway that suppresses lipogenesis. Insulin robustly upregulates zinc-f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yan, Jiang, Lin, Sun, Chengxin, Ireland, Nicole, Shah, Yatrik M., Liu, Yong, Rui, Liangyou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048127/ https://www.ncbi.nlm.nih.gov/pubmed/30013137 http://dx.doi.org/10.1038/s41467-018-05309-y

Ejemplares similares

Cinnamic Acid Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Hepatic Lipogenesis and Promoting Fatty Acid Oxidation
por: Wu, You, et al.
Publicado: (2021)

Ruscogenin Ameliorates Experimental Nonalcoholic Steatohepatitis via Suppressing Lipogenesis and Inflammatory Pathway
por: Lu, Hung-Jen, et al.
Publicado: (2014)

Hepatic NF-kB-inducing kinase (NIK) suppresses mouse liver regeneration in acute and chronic liver diseases
por: Xiong, Yi, et al.
Publicado: (2018)

Raphani Semen (Raphanus sativus L.) Ameliorates Alcoholic Fatty Liver Disease by Regulating De Novo Lipogenesis
por: Park, Woo Yong, et al.
Publicado: (2021)

Hepatic NF‐κB‐Inducing Kinase and Inhibitor of NF‐κB Kinase Subunit α Promote Liver Oxidative Stress, Ferroptosis, and Liver Injury
por: Zhong, Xiao, et al.
Publicado: (2021)

Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease
por: ter Horst, Kasper W., et al.
Publicado: (2017)

GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance
por: Taher, Jennifer, et al.
Publicado: (2014)

Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance
por: Roumans, Kay H. M., et al.
Publicado: (2020)

Aqueous Mulberry Leaf Extract Ameliorates Alcoholic Liver Injury Associating with Upregulation of Ethanol Metabolism and Suppression of Hepatic Lipogenesis
por: Lee, Yi-Ju, et al.
Publicado: (2021)

Clitorin ameliorates western diet-induced hepatic steatosis by regulating lipogenesis and fatty acid oxidation in vivo and in vitro
por: Cominguez, Divina C., et al.
Publicado: (2022)

HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer
por: Lu, Xiaodong, et al.
Publicado: (2022)

Regulation of Lipogenesis by Glucocorticoids and Insulin in Human Adipose Tissue
por: Gathercole, Laura L., et al.
Publicado: (2011)

LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease
por: Liu, Jun, et al.
Publicado: (2019)

Targeting the IL-6–Yap–Snail signalling axis in synovial fibroblasts ameliorates inflammatory arthritis
por: Symons, Rebecca A, et al.
Publicado: (2022)

Diosgenin Ameliorated Type II Diabetes-Associated Nonalcoholic Fatty Liver Disease through Inhibiting De Novo Lipogenesis and Improving Fatty Acid Oxidation and Mitochondrial Function in Rats
por: Zhong, Yujie, et al.
Publicado: (2022)

Epigenetic suppression of E-cadherin expression by Snail2 during the metastasis of colorectal cancer
por: Hu, Yue, et al.
Publicado: (2018)

Abelmoschus esculentus subfractions ameliorate hepatic lipogenesis and lipid uptake via regulating dipeptidyl peptidase-4—With improving insulin resistance
por: Peng, Chiung-Huei, et al.
Publicado: (2022)

Risk of diabetes associated with fatty acids in the de novo lipogenesis pathway is independent of insulin sensitivity and response: the Insulin Resistance Atherosclerosis Study (IRAS)
por: Qureshi, Waqas, et al.
Publicado: (2019)

The Role of Dietary Sugars and De novo Lipogenesis in Non-Alcoholic Fatty Liver Disease
por: Moore, J. Bernadette, et al.
Publicado: (2014)

Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease
por: Paglialunga, Sabina, et al.
Publicado: (2016)

Fatty Liver Due to Increased de novo Lipogenesis: Alterations in the Hepatic Peroxisomal Proteome
por: Knebel, Birgit, et al.
Publicado: (2019)

Muscleblind-like 1 destabilizes Snail mRNA and suppresses the metastasis of colorectal cancer cells via the Snail/E-cadherin axis
por: Tang, Liang, et al.
Publicado: (2019)

Upregulation of WDR6 drives hepatic de novo lipogenesis in insulin resistance in mice
por: Yao, Zhenyu, et al.
Publicado: (2023)

Inhibiting both proline biosynthesis and lipogenesis synergistically suppresses tumor growth
por: Liu, Miao, et al.
Publicado: (2020)

LncRNA MALAT1 Promotes PPARα/CD36-Mediated Hepatic Lipogenesis in Nonalcoholic Fatty Liver Disease by Modulating miR-206/ARNT Axis
por: Xiang, Juan, et al.
Publicado: (2022)

Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2021)

Artemether Ameliorates Non-Alcoholic Steatohepatitis by Repressing Lipogenesis, Inflammation, and Fibrosis in Mice
por: Xu, Jia, et al.
Publicado: (2022)

Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
por: Green, Charlotte J, et al.
Publicado: (2020)

High phosphate diet suppresses lipogenesis in white adipose tissue
por: Imi, Yukiko, et al.
Publicado: (2018)

The Short-Term Effects of Soft Pellets on Lipogenesis and Insulin Sensitivity in Rats
por: Bae, Cho-Rong, et al.
Publicado: (2014)

Granulocytic MDSC with Deficient CCR5 Alleviates Lipogenesis and Inflammation in Nonalcoholic Fatty Liver Disease
por: Liao, Tzu-Chieh, et al.
Publicado: (2022)

Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with nonalcoholic fatty liver
por: Fu, Xiaorong, et al.
Publicado: (2023)

Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene
por: Han, Yamei, et al.
Publicado: (2019)

Correction: Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2023)

Amelioration of Hepatic Steatosis in Mice through Bacteroides uniformis CBA7346-Mediated Regulation of High-Fat Diet-Induced Insulin Resistance and Lipogenesis
por: Lee, Hye-Bin, et al.
Publicado: (2021)

Azidothymidine Downregulates Insulin-Like Growth Factor-1 Induced Lipogenesis by Suppressing Mitochondrial Biogenesis and Mitophagy in Immortalized Human Sebocytes
por: Yoo, Jin Gwi, et al.
Publicado: (2021)

A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid utilization
por: Liu, Sihao, et al.
Publicado: (2013)

Trimetazidine improves hepatic lipogenesis and steatosis in non-alcoholic fatty liver disease via AMPK-ChREBP pathway
por: Zhang, Ying, et al.
Publicado: (2020)

Snail augments fatty acid oxidation by suppression of mitochondrial ACC2 during cancer progression
por: Yang, Ji Hye, et al.
Publicado: (2020)

Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model
por: Shi, Dongmei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8ev608djikgkp2pa0jti1pvgpb